Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oat β-glucans as a Supplement in Chilean Subjects With Type 2 Diabetes for Metabolic Control

NCT04299763 is registered in ClinicalTrials.gov with Centro de Estudios en Alimentación y Nutrición, Chile as lead sponsor.

NCT NCT04299763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04299763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oat β-glucans as a Supplement in Chilean Subjects With Type 2 Diabetes for Metabolic Control
Lead sponsor
Centro de Estudios en Alimentación y Nutrición, Chile
Phase
Phase 2
Overall status
Completed
Start date
June 19, 2018
Completion date
January 18, 2019
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type2 diabetes